配列特異性アルキル化による二重鎖ヒトテロメアの繰り返し配列のピロロイミダゾールポリアミドによるインドルリンクナーによる配列特異性アルキル化
Shunta Sasaki1, Toshikazu Bando, Masafumi Minoshima
1Department of Chemistry, Graduate School of Science, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo, Kyoto, 606-8502, Japan.
Journal of the American Chemical Society
|September 14, 2006
まとめ
新しいピロールイミダゾールヘアピンポリアミド (セコ-CBIコンジュガット1と2) は,ヒトのテロメア配列を効果的に標的にします. これらの化合物は,強力なDNAアルキレーションと癌細胞に対する細胞毒性により,抗腫瘍薬として有意な潜在能力を示しています.
科学分野:
- 薬用化学 薬用化学について
- 分子生物学は分子生物学である.
- がん研究 がん研究
背景:
- 人間のテロメアリピートシーケンス (HTRS) は,抗がん薬の開発のターゲットです.
- ピロールイミダゾール (Py-Im) ヘアピンポリアミドは,特定のDNA配列を結合するように設計されています.
研究 の 目的:
- HTRSを標的とした新しいセコ-CBI結合体を合成し,評価する.
- 人間の癌細胞系に対するこれらの結合体のDNAアルキル化と細胞毒性活動を評価する.
主な方法:
- ピロールイミダゾールヘアピンポリアミドセコ-CBIコンジュガートの合成.
- DNAアルキレーション分析のための高解像度デナチュレーションポリアクリルアミドゲル電泳.
- 39のヒトがん細胞系における細胞毒性アッセイ (IC50決定)
主要な成果:
- 結合物質1と2が成功して合成され,標的HTRS配列の3'Aで特定のDNAアルキル化が実証されました.
- 平均ログ IC50値は,コンジュガット1では -6.96 (110 nM),コンジュガット2では -7.24 (57.5 nM) でした.
- 両方のコンジュガートは,幅広い種類の癌細胞系に対して強力な細胞毒性を示した.
結論:
- Seco-CBIコンジュガート1と2は,ヒトのテロメアの繰り返し配列を標的とした効果的なDNAアルキル化剤です.
- これらの新しい化合物は,潜在的な抗腫瘍薬として有望であることを示しています.
さらに関連する動画
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
05:412D-HELS MS Seq: A General LC-MS-Based Method for Direct and de novo Sequencing of RNA Mixtures with Different Nucleotide Modifications
Published on: July 10, 2020
関連する概念動画
01:57Sanger Sequencing
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
03:21RNA-seq
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...
01:05Maxam-Gilbert Sequencing
In the same year as the discovery of the Sanger sequencing method, another group of scientists, Allan Maxam and Walter Gilbert, demonstrated their chemical-cleavage method for DNA sequencing. The Maxam-Gilbert method relies on using different chemicals that can cleave the DNA sequence at specific sites, the separation of resulting DNA fragments of variable size using electrophoresis, and deciphering the DNA sequence from the resulting gel bands.
Challenges of the Maxam-Gilbert Method
The...
Challenges of the Maxam-Gilbert Method
The...